axoCells™ Human iPSC-Derived Ventricular Cardiomyocytes, male donor, ≥1 million cells
axoCells Human iPSC-Derived Ventricular Cardiomyocytes (=1 million cells) for cardiovascular research. Ventricular cardiomyocytes made from iPSCs generated from a 74 year old male donor's pulmonary fibroblasts.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
axoCells Human iPSC-Derived Ventricular Cardiomyocytes (≥1 million cells) for cardiovascular research. Ventricular cardiomyocytes made from iPSCs generated from a 74-year-old male donor's pulmonary fibroblasts.
Key highlights include:
- Spontaneously beat 3 days post-thaw and assay-ready in just 7 days
- Validated against all 28 CiPA compounds
- Demonstrate functional responses in a range of assay formats including patch clamp, electrophysiology, and voltage-sensitive dyes
They are frequently used to fuel in vitro cardiotoxicity models to assess drug safety and for cardiac research. They can also be used in co-culture with other cells (including atrial cardiomyocytes).
